Nightstar Raises $45 Million to Fund Development of Gene Therapies for Blinding Retinal Diseases

BOSTON & LONDON--(BUSINESS WIRE)--Nightstar Raises $45 Million to Fund Development of Gene Therapies for Blinding Retinal Diseases

Full Story →